IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CUGNO, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 17.644
NA - Nord America 16.352
AS - Asia 14.674
Continente sconosciuto - Info sul continente non disponibili 2.472
SA - Sud America 1.486
AF - Africa 358
OC - Oceania 67
Totale 53.053
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.653
GB - Regno Unito 5.995
SG - Singapore 4.391
CN - Cina 4.143
DE - Germania 3.070
IT - Italia 2.820
RU - Federazione Russa 1.296
SE - Svezia 1.229
BD - Bangladesh 1.187
HK - Hong Kong 1.127
VN - Vietnam 1.122
BR - Brasile 1.062
FR - Francia 711
IN - India 659
TR - Turchia 601
NL - Olanda 508
CA - Canada 478
KR - Corea 455
IE - Irlanda 447
UA - Ucraina 423
FI - Finlandia 377
EU - Europa 281
JP - Giappone 203
ID - Indonesia 202
CO - Colombia 184
DK - Danimarca 118
CI - Costa d'Avorio 106
PL - Polonia 106
AR - Argentina 104
GR - Grecia 87
IQ - Iraq 80
ES - Italia 78
MX - Messico 74
BE - Belgio 71
AU - Australia 54
AT - Austria 53
PH - Filippine 49
UZ - Uzbekistan 49
SA - Arabia Saudita 48
PK - Pakistan 47
ZA - Sudafrica 46
TW - Taiwan 45
RO - Romania 44
CH - Svizzera 40
TH - Thailandia 37
EG - Egitto 36
MY - Malesia 35
JM - Giamaica 34
MA - Marocco 34
EC - Ecuador 32
VE - Venezuela 29
CZ - Repubblica Ceca 28
IL - Israele 27
PT - Portogallo 27
TN - Tunisia 26
CR - Costa Rica 25
IR - Iran 24
BG - Bulgaria 20
CL - Cile 19
NP - Nepal 19
KE - Kenya 17
AE - Emirati Arabi Uniti 16
PY - Paraguay 16
DZ - Algeria 15
UY - Uruguay 14
KZ - Kazakistan 13
BO - Bolivia 12
LY - Libia 12
NZ - Nuova Zelanda 12
PE - Perù 12
SC - Seychelles 12
RS - Serbia 11
TT - Trinidad e Tobago 11
JO - Giordania 10
LT - Lituania 10
NO - Norvegia 10
PA - Panama 10
HU - Ungheria 9
SN - Senegal 9
AL - Albania 8
BB - Barbados 8
DO - Repubblica Dominicana 8
HN - Honduras 8
KW - Kuwait 8
LB - Libano 8
LU - Lussemburgo 8
NG - Nigeria 8
NI - Nicaragua 8
AZ - Azerbaigian 7
ET - Etiopia 7
HR - Croazia 7
OM - Oman 7
PR - Porto Rico 7
BY - Bielorussia 6
GT - Guatemala 6
KG - Kirghizistan 6
QA - Qatar 6
AM - Armenia 5
CG - Congo 5
GE - Georgia 5
Totale 50.752
Salva come PNG Salva come JPEG
Città #
Southend 5.509
Singapore 2.658
Ashburn 1.665
Chandler 1.101
Hong Kong 1.031
Milan 962
San Jose 939
Hanover 924
Beijing 842
Seattle 772
Council Bluffs 748
Santa Clara 680
Princeton 619
Dallas 608
Wilmington 547
Fairfield 466
Dublin 444
Los Angeles 373
Frankfurt am Main 350
Ann Arbor 311
New York 308
Houston 283
Woodbridge 277
Jacksonville 259
Lauterbourg 258
Bengaluru 251
Redmond 251
Ho Chi Minh City 244
Somerville 240
Nanjing 229
Buffalo 223
Hanoi 208
Des Moines 202
Guangzhou 199
Boardman 197
Mountain View 196
Moscow 190
Toronto 190
Dearborn 188
Dong Ket 181
Cambridge 177
Sakarya 164
Shanghai 155
Bogotá 153
Andover 144
Helsinki 136
Hefei 134
Rome 133
Odernheim 123
Serra 122
Jakarta 120
Berlin 119
Phoenix 119
Jinan 117
Tokyo 114
Redwood City 110
São Paulo 109
Abidjan 105
Cangzhou 103
Munich 98
Hangzhou 96
Shenyang 96
Columbus 93
Naples 84
Tianjin 81
Chicago 79
Seoul 78
The Dalles 75
Warsaw 71
Nanchang 70
Changsha 68
Athens 67
Geisenheim 66
Grafing 63
Brussels 59
London 55
Shenzhen 51
Turin 51
Fuzhou 50
San Diego 50
Fremont 49
Jiaxing 49
Florence 48
Istanbul 47
Hebei 46
Zhengzhou 45
Bitonto 44
Da Nang 44
Nuremberg 44
Montreal 42
Washington 39
Orem 37
Brooklyn 36
Eitensheim 35
Haiphong 34
Wuhan 34
Bologna 33
Mumbai 33
Taipei 33
Bangkok 32
Totale 30.885
Salva come PNG Salva come JPEG
Nome #
Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin 546
Increased risk of venous thromboembolism in patients with bullous pemphigoid : the INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study 535
IgM Autoantibodies to Complement Factor H in Atypical Hemolytic Uremic Syndrome 525
Validation of the Predictive Model of the European Society of Cardiology for Early Mortality in Acute Pulmonary Embolism 458
Tight glycemic control does not affect asymmetric-dimethylarginine in septic patients 439
The influence of genetic variations on activation of blood coagulation: a possible explanations for the increased thrombotic risk in bullous pemphigoid 437
Relationship between thrombin generation parameters and prothrombin fragment 1 + 2 plasma levels 426
Chronic heart failure and the immune system 423
Measurement of activated factor XII in health and disease 414
Activation of inflammation, coagulation and fibrinolysis in patients with Rheumatoid Arthritis : inhibition by Tumor Necrosis Factor alpha blockade 408
Oral Manifestations Associated with Rheumatic Diseases 393
Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment : relationships with endothelial function, coagulation and inflammation 376
Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis : effects of tumor necrosis factor-alpha blockade 371
Time course of endogenous nitric oxide inhibitors in severe sepsis in humans 370
Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation 357
The Pathogenesis of Chronic Spontaneous Urticaria : The Role of Infiltrating Cells 351
Complement activation and endothelial perturbation parallel COVID-19 severity and activity 326
Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner 321
Paradoxical Autoinflammatory Skin Reaction to Tumor Necrosis Factor Alpha Blockers Manifesting as Amicrobial Pustulosis of the Folds in Patients With Inflammatory Bowel Diseases 309
Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome : evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patients 302
Current and Emerging Treatment Options for Patients with Relapsed Myeloma 301
Enhanced tissue factor expression by blood eosinophils from patients with hypereosinophilia: a possible link with thrombosis 301
Effects of selective alpha1- and alpha2-adrenergic blockade on coronary flow reserve after coronary stenting 299
Paradoxical Skin Reactions to Biologics in Patients With Rheumatologic Disorders 287
Haploidentical Hematopoietic Stem Cell Transplant Complicated by Atypical Hemolytic Uremic Syndrome and Kidney Transplant from the Same Donor with No Immunosuppression but C5 Inhibition 283
Angiotensin-converting enzyme insertion/deletion gene polymorphism in inflammatory bowel diseases 276
Activation of blood coagulation in two prototypic autoimmune skin diseases: a possible link with thrombotic risk 274
Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality 273
Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment : relationships with endothelial function, coagulation and inflammation 271
The genetics of the alternative pathway of complement in the pathogenesis of HELLP syndrome 268
Complement activation in patients with COVID-19: a novel therapeutic target 262
Autochthonous ST405 NDM-5 producing Escherichia coli causing fatal sepsis in Northern Italy 259
Plasma levels of C1- inhibitor complexes and cleaved C1- inhibitor in patients with hereditary angioneurotic edema 257
Main Oral Manifestations in Immune-Mediated and Inflammatory Rheumatic Diseases 257
Salvage therapy with high dose Intravenous Immunoglobulins in acquired Von Willebrand Syndrome and unresponsive severe intestinal bleeding 255
A novel CD46 mutation in a patient with microangiopathy clinically resembling thrombotic thrombocytopenic purpura and normal ADAMTS13 activity 250
Kallikrein-kinin system in inflammatory bowel diseases: Intestinal involvement and correlation with the degree of tissue inflammation 249
Anti-tumor necrosis factor alpha therapy normalizes fibrinolysis impairment in patients with active rheumatoid arthritis 247
Thrombotic microangiopathy without renal involvement carrying two novel mutations in complement-regulator genes 247
Effetto della terapia con infliximab sui marcatori di infiammazione, coagulazione e fibrinolisi nell’artrite reumatoide 246
Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome: an update 244
Haemostatic and inflammatory biomarkers in patients with rheumatoid arthritis : effect of tumor necrosis factor alpha blockade 243
Recurrence of HUS related to Factor H Antibodies after kidney transplantation 243
Cytokine and Chemokine Profile in Amicrobial Pustulosis of the Folds: Evidence for Autoinflammation 242
Involvement of the IgE-basophil system and mild complement activation in haemophilia B with anti-factor IX neutralizing antibodies and anaphylaxis 242
Tight glycemic control may favor fibrinolysis in patients with sepsis 237
Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis 236
A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors 235
Co‐occurrence of IgE and IgG autoantibodies in patients with chronic spontaneous urticaria 232
Patients with antiphospholipid syndrome display endothelial perturbation 230
Omalizumab for the Treatment of Chronic Spontaneous Urticaria in Adults and Adolescents: An Eight-Year Real-Life Experience 228
Angioedema due to angiotensin-converting enzyme inhibitors 228
Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma 226
Blood levels of homocysteine, folate, vitamin B-6 and B-12 in women using oral contraceptives compared to non-users 225
Activation of the coagulation cascade in C1- inhibitor deficiencies 225
Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome 225
Antibodies to tissue-type plasminogen activator (t-PA) in patients with inflammatory bowel disease : high prevalence, interactions with functional domains of t-PA and possible implications in thrombosis 224
Kallikrein-kinin system activation in Crohn's disease : differences in intestinal and systemic markers 224
Haemostatic and inflammatory biomarkers in patients with active Rheumatoid Arthritis : effects of Tumor Necrosis Factor alpha blockade 220
Non neutralizing antibodies to tissue type plasminogen activator in serum of acute myocardial infarction patients treated with the recombinant protein 220
Acquired Complement Regulatory Gene Mutations and Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy 220
Pathogenetic and clinical aspects of C1-inhibitor deficiency 219
Different rates of autoreactivity in patients with recurrent idiopathic angioedema associated or not with wheals 219
Attivazione della coagulazione nelle dermatosi bollose autoimmuni 218
Ongoing contact activation in patients with hereditary angioedema 218
Mechanisms of Inflammation in Neutrophil-Mediated Skin Diseases 217
New insights into the pathogenesis of bullous pemphigoid : 2019 update 217
Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency 215
Homocysteine concentration in primary and systemic sclerosis associated Raynaud's phenomenon 214
C1-inhibitor deficiency and angioedema : molecular mechanisms and clinical progress 211
Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria 210
Bradykinin and the pathophysiology of angioedema 208
Antiphospholipid antibodies and ex-vivo endothelial perturbation 207
Fibrinolytic response in normal subjects to venous occlusion and DDAVP infusion 207
t-PA activity elicited by venous occlusion or DDAVP infusion does not produce plasmin activity in normal subjects 205
Increased levels of soluble interleukin-2 receptors in serum of patients with lung cancer 203
Homocysteine concentration in primary and systemic sclerosis associated Raynaud's phenomenon 203
Use of a Monoclonal antibody (5H5) recognizing FH but not FHL-1 and FHRs to study FH in aHUS patients 202
Increased risk of urticaria/angioedema after BNT162b2 mRNA COVID-19 vaccine in health care workers taking ACE inhibitors 202
Severe chronic urticaria is associated with elevated plasma levels of D-dimer 201
Effect of tumor necrosis factor alpha blockade on inflammatory and haemostatic biomarkers in patients with rheumatoid arthritis 201
Effects of recombinant human activated protein C on the fibrinolytic system of patients undergoing conventional or tight glycemic control 200
Haemostasis contact system and fibrinolysis in hereditary angioedema (C1-inhibitor deficiency) 200
Kidney transplant in patients with atypical hemolytic uremic syndrome in the anti-C5 era: single-center experience with tailored Eculizumab 200
IgG and IgE Autoantibodies to IgE Receptors in Chronic Spontaneous Urticaria and Their Role in the Response to Omalizumab 199
Plasmatic markers of acute attack in patients with angioedemadue to C1 inhibitor deficiency 199
Risk of Atypical HUS Among Family Members of Patients Carrying Complement Regulatory Gene Abnormality 199
Gene Abnormalities in Transplant Associated-Thrombotic Microangiopathy: Comparison between Recipient and Donor's DNA 198
Antihistamines do not inhibit the flare induced by the intradermal injection of autologous plasma in chronic urticaria patients 198
Activation of blood coagulation in bullous pemphigoid : role of eosinophils, and local and systemic implications 197
Lung Ultrasound Findings and Endothelial Perturbation in a COVID-19 Low-Intensity Care Unit 197
Reduction of haemostatic and inflammatory biomarkers by tumor necrosis factor-alpha bockade in patients with rheumatoid arthritis 196
Blood levels of homocysteine, folate, vitamin B6 and B12 in women using oral contraceptives compared to non-users 196
Physiopathology and management of coagulation during long-term extracorporeal respiratory assistance 196
Mortality in Patients with COVID-19 on Renin Angiotensin System Inhibitor Long-Term Treatment : An Observational Study Showing that Things Are Not Always as They Seem 194
Activation of factor XII and cleavage of high molecular weight kininogen during acute attacks in hereditary and acquired C1-inhibitor deficiencies 193
Antibodies to tissue-type plasminogen activator in patients with inflammatory bowel disease 193
Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction. A comparison between streptokinase and recombinant tissue-type plasminogen activator 193
Bradykinin in the ascitic fluid of patients with liver cirrhosis 193
Tissue-type plasminogen activator and von Willebrand factor plasma levels as markers of endothelial involvement in patients with Raynaud's phenomenon 192
Totale 26.228
Salva come PNG Salva come JPEG
Categoria #
all - tutte 140.947
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 140.947
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.860 0 0 249 298 360 259 439 423 505 421 300 606
2022/20233.800 576 414 325 397 398 751 56 234 365 50 178 56
2023/20242.284 94 189 112 147 593 165 101 125 57 107 262 332
2024/20256.477 259 673 115 649 564 281 334 683 400 605 515 1.399
2025/202614.768 1.362 819 1.395 1.095 1.366 906 1.520 753 1.660 1.049 1.610 1.233
2026/20272.005 911 1.035 59 0 0 0 0 0 0 0 0 0
Totale 53.053